Zagayko, A.L. et al. 2018. The effect of third generation aromatase inhibitors on the several components of experimental metabolic syndrome. Medical and Clinical Chemistry. 4 (Jan. 2018), 41–50. DOI:https://doi.org/10.11603/mcch.2410-681X.2017.v0.i4.8306.